Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]The Netherlands Cancer Institute"
Count: 238
Selected: 0
| NCT ID | Title |
|---|
| NCT04071704 | Assessing Health-related Quality of Life in Sarcoma Patients | ||
| NCT04699292 | International Prospective Registry on Local Treatment Approaches in MLS | ||
| NCT03900806 | Internet-based WOrk-related Cognitive Rehabilitation for Cancer Survivors: a Randomized Controlled Trial | ||
| NCT05148546 | Neoadjuvant Study With Combination Immuno-oncology for Primary Clear Cell Renal Cell Cancer | ||
| NCT03387761 | Neo-Adjuvant Bladder Urothelial Carcinoma COmbination-immunotherapy | ||
| NCT05200988 | Checkpoint Inhibition and Chemoradiotherapy as Bladder Sparing Treatment in UC | ||
| NCT03223727 | Treatment Outcomes in a Non-study Population of Symptomatic mCRPC Patients Treated With Radium-223 | ||
| NCT04871594 | Checkpoint Inhibition With or Without Domatinostat in Urothelial Cancer | ||
| NCT04133948 | Multicenter Phase 1b Trial Testing the Neoadjuvant Combination of Domatinostat, Nivolumab and Ipilimumab in IFN-gamma Signature-low and IFN-gamma Signature-high RECIST 1.1-measurable Stage III Cutaneous or Unknown Primary Melanoma | ||
| NCT03686332 | PEnile Cancer Radio- and Immunotherapy CLinical Exploration Study | ||
| NCT03295565 | Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With Docetaxel | ||
| NCT03223597 | Registry of Treatment Outcomes of Symptomatic Metastasized Castration Resistant Prostate Cancer Treated With Radium-223 | ||
| NCT02977052 | Optimal Neo-adjuvant Combination Scheme of Ipilimumab and Nivolumab | ||
| NCT02437279 | Study to Identify the Optimal Adjuvant Combination Scheme of Ipilimumab and Nivolumab in Melanoma Patients | ||
| NCT02278887 | Study Comparing TIL to Standard Ipilimumab in Patients With Metastatic Melanoma | ||
| NCT05131919 | Pembrolizumab for Locally Advanced, Irresectable, Non-metastatic dMMR Colorectal Cancers | ||
| NCT04949113 | Neoadjuvant Ipilimumab Plus Nivolumab Versus Standard Adjuvant Nivolumab in Macroscopic Stage III Melanoma | ||
| NCT05314309 | Prospective Clinical Validation of a Novel Multitarget FIT in CRC Screening | ||
| NCT03815890 | Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO | ||
| NCT05301881 | COntinue the SaMe Systemic Therapy After Local Ablative Therapy for Oligo Progression in Metastatic Breast Cancer - the COSMO Study | ||
| NCT01780675 | Hippocampus Avoidance PCI vs PCI | ||
| NCT04307329 | Monalizumab and Trastuzumab In Metastatic HER2-pOSitive breAst Cancer: MIMOSA-trial | ||
| NCT04159818 | Immune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple Negative Breast Cancer (TNBC) Patients | ||
| NCT03819829 | Blood Sampling of Healthy Volunteers for Immunological Research | ||
| NCT03147040 | AssessinG Efficacy of Carboplatin and ATezOlizumab in Metastatic Lobular Breast Cancer | ||
| NCT03126812 | Neo-adjuvant Pembrolizumab in Primary Stage IV Ovarian Cancer | ||
| NCT02826512 | A Feasibility Study of Niraparib for Advanced, BRCA1-like, HER2-negative Breast Cancer Patients | ||
| NCT02810743 | Substantially Improving the Cure Rate of High-risk BRCA1-like Breast Cancer | ||
| NCT02499367 | Nivolumab After Induction Treatment in Triple-negative Breast Cancer (TNBC) Patients | ||
| NCT02285179 | Clinical Trial to Evaluate the Safety and Effectiveness of GDC-0032 When Given Alongside Tamoxifen | ||
| NCT01996267 | Neoadjuvant Chemotherapy in HER2 Positive Breast Cancer, TRAIN-2 | ||
| NCT01898117 | Triple-B Study;Carboplatin-cyclophosphamide Versus Paclitaxel With or Without Atezolizumab as First-line Treatment in Advanced Triple Negative Breast Cancer | ||
| NCT01646034 | High Dose Chemotherapy in Oligo-metastatic Homologous Recombination Deficient Breast Cancer | ||
| NCT04916236 | Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers | ||
| NCT04682470 | The Prospective Observational COMPRAYA Cohort Study | ||
| NCT05251389 | FMT to Convert Response to Immunotherapy | ||
| NCT03348150 | Gastrectomy + Cytoreductive Surgery + HIPEC for Gastric Cancer With Peritoneal Dissemination. | ||
| NCT04330430 | Neo-adjuvant T-VEC + Nivolumab Combination Therapy for Resectable Early Metastatic (Stage IIIB/C/D-IV M1a) Melanoma With Injectable Disease | ||
| NCT05209750 | FAPI PET/CT for Lymph Node Staging in Colorectal Carcinoma | ||
| NCT02715141 | Molecular Stool Testing for Colorectal Cancer Surveillance | ||
| NCT03968679 | Lymph Drainage Mapping for Tailoring Elective Nodal Irradiation in Head and Neck Cancer | ||
| NCT02931890 | Multicentric Randomised Trial for Resectable Gastric Cancer | ||
| NCT01024829 | Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using FDG-PET-CT Scan in Stage IB, II and III NSCLC | ||
| NCT00212121 | Radiation Dose Intensity Study in Breast Cancer in Young Women | ||
| NCT05162573 | EBRT + Lu-PSMA for N1M0 Prostate Cancer | ||
| NCT05153733 | Improved Implant for Reconstruction Purposes After Mandibular Resection | ||
| NCT02913729 | Pre- Versus Postoperative Accelerated Partial Breast Irradiation | ||
| NCT04648189 | Cetuxibab to Reduce Circulating Tumor Cells in Early Stage NSCLC | ||
| NCT01164995 | Study With Wee-1 Inhibitor MK-1775 and Carboplatin to Treat p53 Mutated Refractory and Resistant Ovarian Cancer | ||
| NCT04518124 | Propranolol in Angiosarcoma |
